Equities researchers at B. Riley Financial started coverage on shares of Nutex Health (NASDAQ:NUTX – Get Free Report) in a note issued to investors on Friday. The firm set a “buy” rating and a $325.00 price target on the stock. B. Riley Financial’s price objective suggests a potential upside of 69.50% from the stock’s current price.
A number of other equities analysts have also commented on NUTX. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 24th. Lake Street Capital reissued a “buy” rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Finally, Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $317.50.
Check Out Our Latest Report on Nutex Health
Nutex Health Stock Down 3.0%
Nutex Health (NASDAQ:NUTX – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The company had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million.
Institutional Trading of Nutex Health
Institutional investors have recently modified their holdings of the company. Kilter Group LLC acquired a new position in shares of Nutex Health in the second quarter valued at $27,000. Allworth Financial LP acquired a new stake in Nutex Health during the second quarter worth $35,000. Islay Capital Management LLC bought a new stake in Nutex Health in the 4th quarter valued at $34,000. BNP Paribas Financial Markets raised its stake in shares of Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after buying an additional 290 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in shares of Nutex Health by 752.4% in the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after buying an additional 316 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.
About Nutex Health
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Read More
- Five stocks we like better than Nutex Health
- Defense Stocks Are Pulling Back as Their Navy Tailwinds Get Stronger
- Survey Reveals: America’s Top Autumn Activities that are Free [2026]
- Defying Gravity: Space Stocks Reach Escape Velocity
- Credo Technology Just Plunged 20%—Did the Market Overreact?
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
